PDS Biotechnology (PDSB) and Farmacore Announce Updates to Co-Development of Versamune-Based COVID-19 Vaccine

Go back to PDS Biotechnology (PDSB) and Farmacore Announce Updates to Co-Development of Versamune-Based COVID-19 Vaccine
(NASDAQ: PDSB) Delayed: 0.84 --0 (-0%)
Previous Close $0.84    52 Week High
Open $0.82    52 Week Low
Day High $0.88    P/E N/A 
Day Low $0.75    EPS
Volume 13,572,708